Document:

EX-10.4

 Exhibit 10.4 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between LIFETIME BRANDS, INC. (the
“Company”) and DANIEL SIEGEL (the “Executive”) as of November 8, 2017. 
 WHEREAS, the Company and
the Executive previously entered into that certain employment agreement dated November 28, 2014 (the “Prior Agreement”); 

WHEREAS, the Prior Agreement shall have expired by its terms on December 31, 2017 and is hereby superseded by this Agreement effective as
of the Effective Date (as defined in Section 1(a) below), such that from and after the Effective Date, the rights and obligations of the parties shall be provided solely in this Agreement, and the Prior Agreement shall be of no further force
and effect; and 
 WHEREAS, the Company desires to continue to employ the Executive as its President and the Executive desires to continue
to serve in such capacity on behalf of the Company. 
 NOW, THEREFORE, in consideration of the premises and of the mutual covenants and
agreements hereinafter set forth, the Company and the Executive hereby agree as follows: 
 1. Employment. 

(a) Term. The Executive’s term of employment under this Agreement shall begin on January 1, 2018 (the “Effective
Date”), and shall continue until December 31, 2020, and shall automatically renew for consecutive one year periods, unless (i) either party gives the other party written notice (“Notice of
Non-Renewal”) at least 90 days prior to the end of the initial term or any one-year renewal period that the term of the Agreement shall not be further extended
or (ii) sooner terminated by either party as set forth below. The Executive’s period of employment under this Agreement is referred to herein as the “Term.” 

(b) Duties. During the Term, the Executive shall serve as the President of the Company with duties, responsibilities and authority
commensurate therewith and shall report to the Chief Executive Officer (the “CEO”) of the Company. The Executive shall perform all duties and accept all responsibilities incident to such position as may be reasonably assigned to the
Executive by the CEO. The Executive represents to the Company that the Executive is not subject to or a party to any employment agreement, non-competition covenant, or other agreement that would be breached
by, or prohibit the Executive from executing, this Agreement and performing fully the Executive’s duties and responsibilities hereunder. 

(c) No Other Employment. During the Term, the Executive shall not, directly or indirectly, render services to any other person or
organization for which he receives compensation; provided, however, that upon the receipt of the Company’s prior written approval, which approval shall not unreasonably be withheld, the Executive may accept election to the board of directors of
not more than one other company provided that such activities do not otherwise conflict with his duties and obligations to the Company. No such approval will be required if the Executive wishes to perform services without direct compensation
therefor in connection with the management of personal investments or in connection with the performance of charitable and civic activities, provided that such activities do not contravene the purposes of this Agreement. 

 (d) Principal Place of Employment. The Executive’s principal office location shall be
at the Company’s office in Garden City, New York; provided, however, that the Executive recognizes that frequent travel, both within and outside the United States, shall be required in connection with his responsibilities under this Agreement.

 2. Compensation. 
 (a)
Base Salary. During the Term, the Company shall pay the Executive a base salary (“Base Salary”) at the annual rate of (i) $512,500 for the period commencing on the Effective Date and ending June 30, 2019 and (ii)
$550,000 for the period commencing July 1, 2019 and thereafter. Base Salary shall be paid in installments in accordance with the Company’s normal payroll practices. 

(b) Annual Bonuses. For each year during the Term commencing with the year ending December 31, 2018, the Executive shall receive an
“Annual Adjusted IBIT Performance Bonus” and an “Annual Individual Goal Bonus” determined as follows: 

(i) Annual Adjusted IBIT Performance Bonus. The CEO shall prepare and deliver to the Executive within 90 days following
the beginning of each year during the Term commencing with the year ending December 31, 2018 an Adjusted IBIT Performance Bonus Table (the “Adjusted IBIT Performance Bonus Table”) for such year under which (A) the Adjusted
IBIT (as defined in Section 9(a)) to be achieved by the Company for the Executive to obtain 100% of the Adjusted IBIT Target Bonus shall be based on the annual budget for such year prepared by the management of the Company and approved by the
Board of Directors of the Company (the “Board”) and (B) the “Adjusted IBIT Target Bonus” shall be 75% of the Base Salary payable to the Executive for such year. The threshold Adjusted IBIT for such year shall
be 50% of the target Adjusted IBIT for such year which, if achieved, would entitle the Executive to receive 50% of the Adjusted IBIT Target Bonus for such year consistent with the Adjusted IBIT Performance Bonus Table for such year. The maximum
Adjusted IBIT for such year shall be 150% of the target Adjusted IBIT for such year which, if achieved, would entitle the Executive to receive 150% of the Adjusted IBIT Target Bonus for such year, consistent with the Adjusted IBIT Performance Bonus
Table for such year. The Executive shall be entitled to receive the sliding scale percentages of the Adjusted IBIT Target Bonus set forth in the Adjusted IBIT Performance Bonus Table based upon Adjusted IBIT being more than the threshold Adjusted
IBIT but less than the target Adjusted IBIT, or more than the target Adjusted IBIT but less than the maximum Adjusted IBIT; provided, however, that notwithstanding anything to the contrary contained in this Agreement, the Annual Adjusted IBIT
Performance Bonus for any such year shall be zero if the Adjusted IBIT achieved by the Company for such year is less than the threshold Adjusted IBIT for such year, and in no event shall an Annual Adjusted IBIT Performance Bonus for any such year be
more than 150% of the Adjusted IBIT Target Bonus for such year even if the Adjusted IBIT achieved by the Company for such year exceeds the maximum Adjusted IBIT for such year. The Company shall pay the

  
 2 

 
Annual Adjusted IBIT Performance Bonus earned by the Executive for each year in the immediately following year, no later than March 15. Any bonuses payable by the Company to the Executive
pursuant to this Section 2(b)(i) shall be awarded under and subject to the terms of the Company’s 2000 Incentive Bonus Compensation Plan, as amended from time to time (the “Bonus Plan”), subject to any approval of
shareholders of the Company, if required by Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”). 

(ii) Annual Individual Goal Bonuses. For each year during this Agreement commencing with the year ending
December 31, 2018, the Executive shall be eligible to receive an Annual Individual Goal Bonus equal to 37.5% of his Base Salary for such year (“Individual Goal Target Bonus”) based on meeting individual measurable objectives
set by the CEO in consultation with the Executive, as determined by the CEO in his sole discretion; provided, however, that if, in the sole discretion of the CEO, (A) the Executive meets at least 50% of such objectives, he shall be entitled to
an Annual Individual Goal Bonus equal to not less than 50% of the Individual Goal Target Bonus and (B) the Executive meets less than 50% of such objectives, he shall not be entitled to receive any Annual Individual Goal Bonus for such year. The
Annual Individual Goal Bonus will be paid at the same time as the Annual Adjusted IBIT Performance Bonus. 
 (c) Automobile Allowance.
During the Term, the Company shall pay the Executive an automobile allowance in the amount of $1,500 per month. This automobile allowance is intended to cover all expenses associated with the Executive’s use of an automobile for Company
business, so that no other expenses relating to such automobile use will be reimbursed, except gas and tolls incurred in using such automobile for Company business. 

3. Benefit and Compensation Plans. During the Term, the Executive shall be eligible to participate in the Company’s health, dental
and other welfare benefit plans and programs, as well as any pension, profit-sharing, stock award, stock option or similar plan, in each case as may be available to senior executives of the Company from time to time, pursuant to their respective
terms and conditions. Nothing in this Agreement shall preclude the Company or any affiliate of the Company from terminating or amending any employee benefit plan or program from time to time after the Effective Date. 

4. Vacation. During each year of the Term, the Executive shall be entitled to 30 days of paid vacation and holiday and sick leave at
levels commensurate with those provided to other senior executives of the Company, in accordance with the Company’s vacation, holiday and other pay for time not worked policies. 

5. Expenses. Upon submission of proper documentation, which shall be subject to review by the CEO, the Company will pay or reimburse the
Executive for all travel expenses incurred by the Executive on business trips taken with the approval of the CEO outside the metropolitan New York area and for all other business and entertainment expenses reasonably incurred by him in connection
with all pre-approved activities relating to the business of the Company and its subsidiaries during the Term, all in accordance with Company policies then in effect. 

  
 3 

 6. Termination. Upon termination of the Executive’s employment pursuant to this
Section 6, however caused, the Executive shall be entitled to no other payments, compensation, severance or benefits except as expressly stated in this Section 6. 

(a) Termination by the Company without Cause; Termination by Executive for Good Reason. The Company may terminate the Executive’s
employment without Cause at any time upon written notice, or the Executive may terminate his employment with the Company for Good Reason. If the Executive’s employment is terminated by the Company without Cause or the Executive terminates his
employment with the Company for Good Reason and Section 6(c)(i) does not apply, then subject to Section 6(i), the Executive shall be entitled to receive the following: 

(i) an amount equal to two times the Executive’s annual Base Salary as in effect on the termination date, payable in
installments over the 24 month period following the termination date in accordance with the Company’s normal payroll practices (but no less frequently than monthly); 

(ii) the Pro-Rated Performance Bonus (as defined in Section 9(e)) for the fiscal
year in which the effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(iii) an amount equal to two times the Target Bonus (as defined in Section 9(g)), payable within 60 days following the
termination date; 
 (iv) if the Executive timely and properly elects COBRA continuation coverage for medical and dental
benefits and remains eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month period, such
coverage shall be provided to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income to the Executive, to the extent consistent with applicable law;
and 
 (v) accelerated vesting of all of the Executive’s then outstanding stock options and the lapse of all
restrictions on shares of restricted stock granted by the Company to the Executive, subject to the terms of the Company’s 2000 Long-Term Incentive Plan or any successor plan (the “Equity Plan”) and any applicable grant
agreement; 
 (b) Termination Due to Expiration or Non-Renewal of the Term. In the event that
the Executive’s employment terminates upon expiration of the Term following the Company’s delivery of a Notice of Non-Renewal and Section 6(c)(i) does not apply, then subject to
Section 6(i), the Executive shall be entitled to receive the following: 
 (i) an amount equal to the Executive’s
annual Base Salary as in effect upon the expiration of the Term, payable in installments over the 12 month period following the termination date in accordance with the Company’s normal payroll practices (but no less frequently than monthly);

  
 4 

 (ii) the Annual Adjusted IBIT Performance Bonus for the fiscal year in which the
effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(iii) if the Executive timely and properly elects COBRA continuation coverage for medical and dental benefits and remains
eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month period, such coverage shall be provided
to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income to the Executive, to the extent consistent with applicable law; and 

(iv) accelerated vesting of all of the Executive’s then outstanding stock options and the lapse of all restrictions on
shares of restricted stock granted by the Company to the Executive, subject to the terms of the Equity Plan and any applicable grant agreement. 

(c) Termination in connection with a Change of Control. 

(i) In the event that the Executive’s employment is terminated by the Company without Cause, by the Executive for Good
Reason, or upon expiration of the Term following the delivery of a Notice of Non-Renewal by the Company, in each case upon or within two years following a Change of Control (as defined in Section 9(c)),
then subject to Section 6(i), the Executive shall be entitled to receive the following: 
 (A) a cash payment equal to
two times the Executive’s annual Base Salary as in effect on the effective date of the Change of Control, or if greater, two times the Executive’s annual Base Salary in effect on the date of termination, payable in a lump sum within 60
days following the employment termination date; 
 (B) the Pro-Rated Performance
Bonus for the fiscal year in which the effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(C) two times the Target Bonus, payable within 60 days following the termination date; 

(D) if the Executive timely and properly elects COBRA continuation coverage for medical and dental benefits and remains
eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month period, such coverage shall be provided
to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income to the Executive, to the extent consistent with applicable law; and; and 

(E) accelerated vesting of all of the Executive’s then outstanding stock options and the lapse of all restrictions on
shares of restricted stock granted by the Company to the Executive, subject to the terms of the Equity Plan and any applicable grant agreement. 

  
 5 

 For the avoidance of doubt, in the event that the Executive’s employment is terminated in
accordance with this Section 6(c)(i), the Executive shall only be entitled to termination payments and benefits as provided under this Section 6(c)(i) and shall not be entitled to any other termination payments or benefits under any other
section of this Agreement (other than any payments or benefits to which the Executive may be entitled under Section 6(h)). 

(ii) In the event that the Executive’s employment is terminated by the Company without Cause, by the Executive for Good
Reason, or upon expiration of the Term following delivery of a Notice of Non-Renewal by the Company, and in each case, within 90 days following such termination a Change of Control occurs, then within 60 days
following the Change of Control, the Executive shall be entitled to receive (A) a lump sum cash payment equal to the excess of the amount set forth in Section 6(c)(i)(A) less the amount previously paid to the Executive pursuant to
Section 6(a)(i) or Section 6(b)(i), as applicable, and (B) in the event that termination is on account of the Company’s delivery of a Notice of Non-Renewal, the Executive shall be entitled
to receive the amount set forth in Section 6(c)(i)(C) within 60 days following the Change of Control. 
 (iii)
Notwithstanding the foregoing, if and to the extent required by Section 409A of the Code, if a Change of Control does not constitute a “change in control event” as defined by Section 409A of the Code or the lump sum payment in
Section 6(c)(i)(A) or Section 6(c)(ii)(A) would otherwise cause the Executive to incur penalties under Section 409A of the Code, such payment shall not be paid in a lump sum but shall be paid (or, in the case of
Section 6(c)(ii)(A), continue to be paid) in equal installments in accordance with the payroll practices over the two year period following Executive’s termination date. 

(d) Termination by Company for Cause. The Company may terminate the Executive’s employment for Cause at any time upon written
notice to the Executive, in which event all payments under this Agreement shall cease, except for any amounts to which the Executive may be entitled under Section 6(h). 

(e) Voluntary Resignation by Executive without Good Reason. The Executive may voluntarily terminate employment without Good Reason for
any reason upon 30 days prior written notice to the Company; provided that, the Company may waive all or any portion of such notice period without the obligation to provide compensation in respect of any waived portion of the notice period. In such
event, after the effective date of such termination, no payments shall be due under this Agreement, except for any payments or benefits to which the Executive may be entitled under Section 6(h). 

(f) Termination Upon Death of Executive. If the Executive dies during the Term, the Executive’s employment shall terminate on the
date of death and the Company shall pay to the Executive’s executor, legal representative, administrator or designated beneficiary, as applicable, any amounts payable to the Executive under Section 6(h) and any Pro-Rated Performance Bonus accrued through the effective date of his termination of employment to which the Executive may be entitled. Otherwise, the Company shall have no further liability or obligation under this
Agreement to the Executive’s executors, legal representatives, administrators, heirs or assigns or any other person claiming under or through the Executive. 

  
 6 

 (g) Termination Upon Total Disability of Executive. If the Executive incurs
a Total Disability (as defined in Section 9(h)) during the Term, the Company may terminate the Executive’s employment on or after the date of Total Disability. In the event that the Executive’s employment is terminated due to a Total
Disability, then subject to Section 6(i), the Executive shall receive (A) continued payments of the Executive’s Base Salary as then in effect for a period of six months following the effective date of termination, payable in
installments in accordance with the Company’s normal payroll practices (but no less frequently than monthly), provided that payment shall instead be made in a lump sum within 60 days following the termination date, to the extent termination
occurs within two years following a Change of Control which constitutes a change in control event under Section 409A of the Code, and (B) any Pro-Rated Performance Bonus accrued through the effective
date of termination to which the Executive may be entitled. In addition, the Executive shall be entitled to receive any amounts payable to him under Section 6(h). 

(h) Accrued Obligations. In the event of any termination of employment under this Section 6, the Company shall pay to the Executive
(i) the amount of any accrued but unpaid Base Salary and accrued and unused vacation, less applicable withholdings and deductions, through the date of termination, (ii) reimbursement of expenses or allowances in accordance with
Section 5 and not previously reimbursed through the date of termination and (iii) all benefits that are accrued and vested through the date of termination under all employee benefit plans of the Company in which the Executive was a
participant immediately prior to such termination, regardless of whether the Executive executes or revokes the Release (as defined in Section 9(f)). 

(i) Release. Notwithstanding anything in this Section 6 to the contrary, in no event shall the Executive be entitled to receive any
amounts, rights or benefits under Section 6(a), (b), (c) or (g) unless the Executive executes, delivers and, if applicable, does not revoke within any applicable revocation period, a Release and the Release shall have become effective by
its terms prior to the 60th day following the Executive’s termination date. Accordingly, payments under Section 6(a), (b), (c) or (g) shall be paid or commence within 60 days following the Executive’s termination date and
following the effective date of the Release; provided that, any installments that would have otherwise been paid in accordance with payroll practices between the termination date and the date of the first payment shall be paid with the first
payment. 
 7. No Mitigation; No Offset. In no event shall the Executive be obligated to seek other employment or take any other
action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced, regardless of whether the Executive obtains other employment. The Company’s obligation to
make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim,
recoupment, defense or other right which the Company may have against the Executive or others. 

  
 7 

 8. Resignation of Positions. Effective as of the date of any termination of employment,
the Executive will resign all Company-related positions, including as an officer and director of the Company and its parents, subsidiaries and affiliates. 

9. Definitions. For purposes of this Agreement, the following terms shall have the meanings set forth below: 

(a) “Adjusted IBIT”, as it applies to any particular year, means that amount for such year equal to the Company’s Income
Before Income Taxes, as determined by the Company’s independent auditors, using generally accepted accounting principles, and reported in the Company’s Consolidated Statements of Operations in its Annual Report on Form 10-K for such year filed with the Securities and Exchange Commission, subject to such adjustments as are set forth in the Adjusted IBIT Performance Bonus Table for such year (which adjustments, if not set forth
therein, shall be the same as those applied to the bonus arrangements with the other senior executive officers of the Company). 
 (b)
“Cause” means that the Executive has (i) committed any act of willful misconduct, including fraud, in connection with his employment by the Company; (ii) materially breached any provision of this Agreement, which breach
has not been cured within ten business days after receiving written notice of such breach; (iii) failed, refused or neglected, other than by reason of a Total Disability, to timely perform any material duty or obligation under this Agreement or
to comply with any lawful directive of the Board, which failure, refusal or neglect has not been cured within ten business days after receiving written notice thereof; (iv) been formally indicted for a crime involving moral turpitude,
dishonesty, fraud or unethical business conduct; (v) violated a fiduciary obligation to the Company; (vi) been determined by a governmental body or other appropriate authority to have violated any material law or regulation that is
applicable to the Company’s businesses, or entered into a consent order concerning a violation of any material law or regulation that is applicable to the Company’s businesses; or (vii) become the subject of an SEC action or
administrative proceeding which has been commenced against him. Upon a cure of the acts set forth in subsections (ii) or (iii) by the Executive within the ten business day cure period to the reasonable satisfaction of the Board, such event
shall no longer constitute Cause for purposes of this Agreement. 
 (c) “Change of Control” means (A) the consummation
of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s issued shares or securities outstanding
immediately after such merger, consolidation or other reorganization is owned by persons who were not shareholders of the Company 180 days prior to such merger, consolidation or other reorganization; (B) the sale, transfer or other disposition
of all or substantially all of the Company’s assets; (C) a change in the composition of the Board, as a result of which fewer than 50% of the incumbent directors are directors who had been directors of the Company on the date 24 months
prior to the date of the event that may constitute a Change of Control (for example, the current Board has ten directors, a change of six directors shall constitute a Change of Control); (D) any transaction as a result of which any person is the
“beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), directly or indirectly, of securities of the Company
representing at least 50% of the total voting power represented by the Company then outstanding voting 

  
 8 

 
securities (e.g., issued shares). The term “person” shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a trustee or
other fiduciary holding securities under an employee benefit plan of the Company or of any subsidiary of the Company and (ii) a company owned directly or indirectly by the stockholders of the Company in substantially the same proportions as
their ownership of the ordinary shares of the Company. 
 (d) “Good Reason” means the occurrence of any of the following
without the Executive’s prior written consent: (i) a material diminution in the Executive’s duties, or the assignment to the Executive of duties materially inconsistent with the authority, responsibilities and reporting requirements
as set forth in Section 1(b); (ii) the failure of the Board to elect the Executive to the office of President of the Company; (iii) the Company, the Board or any person controlling the Company requires the Executive to relocate his
principal place of employment to a location outside of a 50 mile radius from its current location, over the objection of the Executive unless such relocation is as the result of exigent circumstances as determined by the Board; or (iv) the
failure of the Company to obtain the assumption in writing of its obligations to perform this Agreement by any successor to all or substantially all of the business or assets of the Company not later than the effective date of such transaction. In
the event that the Executive elects to terminate his employment for Good Reason, the Executive shall notify the Company in writing of the grounds for such termination within 30 days of the commencement of such condition and the Company shall have 30
days from the receipt of such notice to cure such condition. The Executive must terminate his employment within the 90-day period following the initial existence of the circumstances constituting Good Reason.

 (e) “Pro-Rated Performance Bonus” for a particular fiscal year means the amount
equal to the Annual Adjusted IBIT Performance Bonus for such fiscal year that would have been payable to the Executive by the Company for such fiscal year, as determined by the Board, if this Agreement had not been terminated during such fiscal year
times a fraction, the numerator of which is the number of months elapsed during such fiscal year up to and including the month in which the termination of the Term occurs and the denominator of which is 12. 

(f) “Release” means a release of claims against the Company in the form attached hereto as Exhibit A, subject to any
legally required changes. 
 (g) “Target Bonus” means 112.5% of the Executive’s annual Base Salary in effect at the
time of termination; provided that, for purposes of Section 6(c), Target Bonus means 112.5% of the greater of (i) the Executive’s annual Base Salary in effect at the time of termination or (ii) the Executive’s annual Base
Salary in effect at the effective date of the Change of Control. 
 (h) “Total Disability” means the failure of the
Executive, after reasonable accommodation, to perform his duties for an aggregate period of 120 consecutive days during any 12 month period by reason of the Executive’s physical or mental disability. The Company’s obligation to pay the
Base Salary to the Executive during such 120 consecutive day period shall be conditioned upon the Executive complying with all requirements under the Company’s short-term and long-term disability insurance policies, as determined in the sole
discretion of the short-term and long-term disability insurance providers. Notwithstanding the foregoing, in the event that the short-term and/or long-term insurance providers pay to the Executive any amounts required to be paid by such insurance
providers under the Company’s short-term and/or long-

  
 9 

 
term disability insurance policies, as applicable, for the 120 consecutive day period prior to the termination of the Executive’s employment due to Total Disability pursuant to
Section 6(g), then during such 120 consecutive day period, the Company shall pay to the Executive only the amount that is the difference between (i) the Executive’s Base Salary and (ii) the disability benefits paid to the
Executive by the short-term and long term insurance providers. Any dispute as to whether or not the Executive is Totally Disabled within the meaning of this Section 9(h) shall be resolved by a physician or other health care professional
selected in good faith by the Executive, and approved by the Board, which approval shall not be unreasonably withheld, and the determination of such physician or other health care professional shall be final and binding upon both the Executive and
the Company. 
 10. Parachute Payments; Section 280G. 

(a) Notwithstanding any other provisions of this Agreement to the contrary, in the event that it shall be determined that any payment or
distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or
otherwise (the “Payments”), would constitute an “excess parachute payment” within the meaning of Section 280G of the Code, the Company shall reduce (but not below zero) the aggregate present value of the Payments to
the Reduced Amount (as defined below), if reducing the Payments under this Agreement will provide the Executive with a greater net after-tax amount than would be the case if no such reduction was
made. The Payments shall be reduced as described in the preceding sentence only if (A) the net amount of the Payments, as so reduced (and after subtracting the net amount of federal, state and local income and payroll taxes on the reduced
Payments), is greater than or equal to (B) the net amount of the Payments without such reduction (but after subtracting the net amount of federal, state and local income and payroll taxes on the Payments and the amount of Excise Tax (as defined
below) to which the Executive would be subject with respect to the unreduced Payments). Any reduction shall be made in accordance with Section 409A of the Code. For purposes of this Section 10(a), (i) the “Reduced Amount”
shall be an amount expressed in present value that maximizes the aggregate present value of Payments under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax, determined in accordance with
Section 280G(d)(4) of the Code, and (ii) the term “Excise Tax” means the excise tax imposed under Section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax. 

(b) All determinations to be made under this Section 10 shall be made by an independent registered public accounting firm or consulting
firm selected by the Company immediately prior to a change of control, which shall provide its determinations and any supporting calculations both to the Company and the Executive within ten days of the change of control. Any such determination
by such firm shall be binding upon the Company and the Executive. All fees and expenses of the accounting or consulting firm in performing the determinations referred to in this Section 10 shall be borne solely by the Company. The
Executive may review the calculations provided by the accounting or consulting firm and may retain another accounting or consulting firm at his own expense for such review and submit objections during such ten day review period. 

  
 10 

 11. Restrictive Covenants. 

(a) Non-Competition. During the Term, the Executive will devote his full available business time
and efforts to promoting and advancing the business of the Company. The Executive hereby agrees that during the Term and for a period of one year thereafter, he will not engage in, be employed by or participate in any way in any country in any
business that (i) the Company is engaging in, or is actively planning to engage in, on the effective date of the Executive’s termination of employment (including without limitation, the sale, manufacture, distribution or marketing of any
kitchenware, bakeware, pantry ware, cutlery, kitchen gadgets, flatware, home decor, picture frames or related products or the licensing of trademarks and brand names therefor) or (ii) accepts or holds a license, dealership, distributorship,
franchise or similar arrangement as to any trademark or product as to which the Company is a licensee, licensor, dealer, distributor, franchisee or franchisor on the effective date of the Executive’s termination (which engagement, employment or
participation includes, but is not limited to, acting as a director, officer, employee, agent, member, manager, managing member, independent contractor, partner, general partner, limited partner, consultant, representative, salesman, licensor or
licensee, franchisor or franchisee, proprietor, syndicate member, stockholder or creditor). Notwithstanding the foregoing, the Executive may own or hold equity securities (or securities convertible into, or exchangeable or exercisable for, equity
securities) of any company or entity that engages in a business that is the same or similar to that of the Company or of its parent entities (if any) or any of its subsidiaries or affiliates; provided, however, that (i) such equity securities
are publicly traded on a securities exchange and (ii) the Executive’s aggregate holdings of such securities do not exceed at any time one (1%) percent of the total issued and outstanding equity securities of such company or entity. 

(b) Non-Solicitation. The Executive agrees that during the Term and for a period of one year
thereafter: 
 (i) Customers and Business. The Executive will not directly or indirectly, either for himself or for
any other person, business, partnership, association, firm, corporation or company (A) call upon, solicit, divert or take away or attempt to solicit, divert or take away (1) any of the customers or prospective customers (i.e., those
customers in existence or being solicited by the Company or any of its subsidiaries at the time of the Executive’s termination of employment with the Company or within 12 months prior thereto) or (2) any business of the Company or any of
its subsidiaries (i.e., those business arrangements concluded or being negotiated and/or developed by the Company or any of its subsidiaries at the time of the termination of the Executive’s employment), or (B) otherwise induce or
influence any such customer or prospective customer to reduce its volume of business, or terminate or divert its relationship or otherwise in any way adversely affect its relationship, with the Company or any of its subsidiaries. 

(ii) Employees. The Executive, on behalf of himself, or any business, firm, corporation, partnership, association,
company or any other entity other than the Company, will not solicit for employment, employ, engage, retain, discuss employment, recruit, attempt to recruit, hire or attempt to hire, or assist any other person to do so in any manner, any person who,
within the prior 12 months, was a director, officer, executive, consultant, advisor, representative or agent of the Company or any of its subsidiaries, or encourage any such person to terminate his or her employment or other

  
 11 

 
relationship with the Company or any of its subsidiaries; provided, however, that the foregoing shall not prohibit general employment solicitations not specifically targeted at directors,
officers, executives, consultants, advisors, representatives or agents of the Company or any of its subsidiaries. 
 (c) Nondisclosure
Obligation. The Executive acknowledges and agrees that the Company and its subsidiaries own, control and have exclusive access to a body of existing technical knowledge and technology, and that the Company and its subsidiaries have expended and
are expending substantial resources in a continuing program of research, development and production with respect to their businesses. The Company and its subsidiaries possess and will continue to possess information that has been or will be created,
discovered or developed, or has or will otherwise become known to the Company and its subsidiaries, and/or in which property rights have been or will be assigned or otherwise conveyed to the Company and its subsidiaries, which information has
commercial value in the businesses in which the Company and its subsidiaries are engaged including information about costs, profits, markets, sales, products, key personnel, pricing policies, operational methods, technical processes and other
business affairs and methods, plans for future development and other information not readily available to the public. All of the aforementioned information is hereinafter called “Confidential Information.” The Executive acknowledges
that his employment by the Company creates a relationship of confidence and trust between the Executive and the Company and its subsidiaries, and that by reason of such employment the Executive will come into possession of, contribute to, and have
access to and knowledge of Confidential Information. The Executive further acknowledges that the services to be performed under this Agreement are of a special, unique, unusual, extraordinary and intellectual character. The Executive further
acknowledges that the businesses of the Company are international in scope, and that the nature of the Executive’s services, position and expertise are such that he is capable of competing with the Company from nearly any location in the
Western hemisphere or Europe. In recognition of the foregoing, the Executive covenants and agrees that during the Term and for five years thereafter, the Executive will use and hold such Confidential Information solely for the benefit of the Company
and its subsidiaries and shall not use such Confidential Information for the Executive’s own benefit or for the benefit of any third party. The Executive shall not, directly or indirectly, disclose or reveal such Confidential Information, in
any manner, to any person other than the Company’s executives unless such information is made or becomes public through disclosure of a party other than the Executive, or such disclosure is required by law and, then, to the extent practicable,
only following prior written notice to the Company. At the termination of his employment, the Executive shall deliver to the Company all notes, letters, documents and records which may contain Confidential Information which are then in his
possession or control and shall destroy any and all copies and summaries thereof. 
 (d) Permitted Conduct. Nothing in this Agreement
shall prohibit or restrict the Executive from lawfully (i) initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by any
governmental or regulatory agency, entity, or official(s) (collectively, “Governmental Authorities”) regarding a possible violation of any law; (ii) responding to any inquiry or legal process directed to the Executive
individually (and not directed to the Company and/or its subsidiaries) from any such Governmental Authorities; (iii) testifying, participating or otherwise assisting in an action or proceeding by any such Governmental Authorities relating to a
possible 

  
 12 

 
violation of law; or (iv) making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal Defend Trade Secrets
Act of 2016, the Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (1) in confidence to a federal, state, or local government
official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made to the Executive’s attorney in relation to a lawsuit for retaliation
against the Executive for reporting a suspected violation of law; or (C) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Nor does this Agreement require the Executive to obtain
prior authorization from the Company before engaging in any conduct described in this paragraph, or to notify the Company that the Executive has engaged in any such conduct. 

(e) Non-Disparagement. The Company and the Executive covenant and agree that during the Term and
following termination of the Term, neither party shall make any disparaging, false or abusive remarks or communications, written or oral, regarding the Executive, on the part of the Company, or the Company, the Company’s products, brands,
trademarks, directors, officers, employees, consultants, advisors, licensors, licensees, customers, vendors or others with which it has a business relationship, on the part of the Executive. 

(f) Remedies. It is specifically understood and agreed that any breach of the provisions of this Section 11 is likely to result in
irreparable injury to the Company or the Executive, as the case may be, and that the remedy at law alone will be an inadequate remedy for such breach, and that, in addition to any other remedy it may have, each party shall be entitled to enforce the
specific performance of this Agreement by the other party and to seek both temporary and permanent injunctive relief (to the extent permitted by law). 

12. Arbitration. Any controversy or claim arising out of or relating to this Agreement (or the breach thereof) shall be settled by final
and binding arbitration in New York, New York by three arbitrators. Except as otherwise expressly provided in this Section 12, the arbitration shall be conducted in accordance with the commercial rules of the American Arbitration Association
(the “Association”) then in effect. One of the arbitrators shall be appointed by the Company, one shall be appointed by the Executive, and the third shall be appointed by the first two arbitrators. If the first two arbitrators
cannot agree on the third arbitrator within 30 days of the appointment of the second arbitrator, then the third arbitrator shall be appointed by the Association. This Section 12 shall not be construed to limit the Company’s or the
Executive’s right to obtain equitable relief under this Agreement with respect to any matter or controversy subject to this Agreement, and, pending a final determination by the arbitrators with respect to any such matter or controversy, the
Company and the Executive shall be entitled to obtain any such relief by direct application to a state, federal or other applicable court, without first being required to arbitrate such matter or controversy and without the necessity of posting a
bond. 
 13. Directors and Officers Insurance. The Executive shall be covered under the Company’s existing directors and officers
insurance policies, as in effect from time to time. 
 14. Survival. The respective rights and obligations of the parties under this
Agreement (including, but not limited to, Section 11) shall survive any termination of the Executive’s employment or termination or expiration of this Agreement to the extent necessary to the intended preservation of such rights and
obligations. 

  
 13 

 15. Section 409A. 

(a) This Agreement is intended to comply with Section 409A of the Code or an exemption, and payments may only be made under this Agreement
upon an event and in a manner permitted by Section 409A of the Code, to the extent applicable. Severance benefits under the Agreement are intended to be exempt from Section 409A of the Code under the “short-term deferral”
exception, to the maximum extent applicable, and then under the “separation pay” exception, to the maximum extent applicable. Notwithstanding anything in this Agreement to the contrary, if required by Section 409A of the Code, if the
Executive is considered a “specified employee” for purposes of Section 409A of the Code and if payment of any amounts under this Agreement is required to be delayed for a period of six months after separation from service pursuant to
Section 409A of the Code, payment of such amounts shall be delayed as required by Section 409A of the Code, and the accumulated amounts shall be paid in a lump sum payment within ten days after the end of the
six-month period. If the Executive dies during the postponement period prior to the payment of benefits, the amounts withheld on account of Section 409A of the Code shall be paid to the personal
representative of the Executive’s estate within 60 days after the date of the Executive’s death. 
 (b) All payments to be made
upon a termination of employment under this Agreement may only be made upon a “separation from service” under Section 409A of the Code. For purposes of Section 409A of the Code, each payment hereunder shall be treated as a
separate payment and the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments. In no event may the Executive, directly or indirectly, designate the calendar year of a payment.
Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the Executive’s execution of the Release, directly or indirectly, result in the Executive designating the calendar year of payment of any amounts
of deferred compensation subject to Section 409A of the Code, and if a payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year. 

(c) All reimbursements and in-kind benefits provided under the Agreement shall be made or provided in
accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the period of time specified in this Agreement, (ii) the amount of
expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in kind benefits to be provided, in any other calendar year, (iii) the reimbursement of an
eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred, and (iv) the right to reimbursement or in kind benefits is not subject to liquidation or exchange for another
benefit. 
 16. Notices. All notices and other communications required or permitted under this Agreement or necessary or convenient in
connection herewith shall be in writing and shall be deemed to have been given when hand delivered or mailed by registered or certified mail, as follows (provided that notice of change of address shall be deemed given only when received): 

  
 14 

 If to the Company, to: 

Lifetime Brands, Inc. 
 1000
Stewart Avenue 
 Garden City, New York 11530 

Attention: CEO 
 with a copy to:

 Lifetime Brands, Inc. 
 1000
Stewart Avenue 
 Garden City, New York 11530 

Attention: Legal Department 
 If
to the Executive, to: 
 Mr. Daniel Siegel 

or, to the most recent address on file with the Company or to such other names or addresses as the Company or the Executive, as the case may be, shall
designate by notice to each other person entitled to receive notices in the manner specified in this Section 16. 
 17.
Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments under this Agreement all federal, state and local taxes as the Company is required to
withhold pursuant to any law or governmental rule or regulation. The Executive shall bear all expenses of, and be solely responsible for, all federal, state and local taxes due with respect to any payment received under this Agreement. 

18. Remedies Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be exclusive of any other remedy,
and each and every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement or now or hereafter existing at law or in equity. No delay or omission by a party in exercising any right, remedy or power
under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in
its sole discretion. 
 19. Assignment. All of the terms and provisions of this Agreement shall be binding upon and inure to the
benefit of and be enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities of the Executive under this Agreement are of a
personal nature and shall not be assignable or delegable in whole or in part by the Executive. The Company may assign its rights, together with its obligations hereunder, in connection with any sale, transfer or other disposition of all or
substantially all of its business and assets, and such rights and obligations shall inure to, and be binding upon, any successor to the business or any successor to substantially all of the assets of the Company, whether by merger, purchase of stock
or assets or otherwise, which successor shall expressly assume such obligations. 

  
 15 

 20. Company Policies. This Agreement and the compensation payable hereunder shall be
subject to any applicable clawback or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to time with respect to officers of the Company. 

21. Entire Agreement; Modifications. This Agreement sets forth the entire agreement of the parties hereto and supersedes any and all
prior agreements and understandings concerning the Executive’s employment by the Company, including but not limited to the Prior Agreement. This Agreement may be amended or modified only by a written document signed by the Executive and the
Company. 
 22. Severability. If any provision of this Agreement or application thereof to anyone or under any circumstances is
adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given effect without the invalid or unenforceable provision or
application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to particular circumstances, it shall nevertheless remain in
full force and effect in all other circumstances. 
 23. Governing Law. This Agreement shall be governed by, and
construed and enforced in accordance with, the substantive and procedural laws of the state of New York without regard to rules governing conflicts of law. Subject to Section 12, any legal action or proceeding brought with
respect to this Agreement shall be brought in the state or federal courts located in New York, New York. If the Executive prevails in any legal or arbitration proceeding commenced in connection with this Agreement, then the Company shall reimburse
the Executive for reasonable attorneys’ fees and costs incurred in connection therewith. 
 24. Indemnification. The Amended and
Restated Indemnification Agreement between the Company and the Executive, dated January 26 2016, shall remain in full force and effect in accordance with its terms. 

25. Counterparts. This Agreement may be executed in any number of counterparts (including facsimile counterparts), each of which shall
be an original, but all of which together shall constitute one instrument. 
 [Signature Page Follows] 

  
 16 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first
above written. 
  

			
	LIFETIME BRANDS, INC.
		
	By:	 	/s/ Ronald Shiftan
		 	Name: Ronald Shiftan
		 	Title: Vice Chairman and COO
	
	EXECUTIVE
	
	 /s/ Daniel Siegel

	Daniel Siegel

  
 17 

 EXHIBIT A 

GENERAL RELEASE 
 I, Daniel Siegel,
the undersigned, agree to accept the payments and benefits set forth on Section 6 of the employment agreement between me and Lifetime Brands, Inc. (the “Company”) dated as of
                 , 2017 (the “Employment Agreement”) in full resolution and satisfaction of, and hereby IRREVOCABLY AND UNCONDITIONALLY RELEASE, REMISE
AND FOREVER DISCHARGE the Company and Releasees from any and all agreements, promises, liabilities, claims, demands, rights and entitlements of any kind whatsoever, in law or equity, whether known or unknown, asserted or unasserted, fixed or
contingent, apparent or concealed, to the maximum extent permitted by law (“Claims”), which I, my heirs, executors, administrators, successors or assigns ever had, now have or hereafter can, shall or may have for, upon, or by reason
of any matter, cause or thing whatsoever existing, arising, occurring or relating to my employment and/or termination thereof with the Company and Releasees, or my economic rights as an equity holder of the Company or Releasees, at any time on or
prior to the date I execute this general release and waiver of Claims (this “Release”), including, without limitation, any and all Claims arising out of or relating to compensation, benefits, any and all contract claims, tort
claims, fraud claims, claims for bonuses, commissions, sales credits, etc., defamation, disparagement, or other personal injury claims, claims for accrued vacation pay, claims under any federal, state or municipal wage payment, harassment,
retaliation, discrimination or fair employment practices law, statute or regulation, and claims for costs, expenses and attorneys’ fees with respect thereto. This Release includes, without limitation, any and all rights and claims under Title
VII of the Civil Rights Act of 1964, the Civil Rights Acts of 1866, 1871 and 1991, Section 1981 of U.S.C., the Employee Retirement Income Security Act, the Age Discrimination in Employment Act (including but not limited to the Older Workers
Benefit Protection Act), the Americans with Disabilities Act, the Genetic Information Non-discrimination Act, the Family and Medical Leave Act, the Equal Pay Act, New York State Human Rights Law, New York
Equal Pay Law, New York Equal Rights Law, New York Off-duty Conduct Lawful Activities Discrimination Law, New York State Labor Relations Act, Article 23-A of the New
York State Corrections Law, New York Whistleblower Statute, New York Family Leave Law, New York Minimum Wage Act, New York Wage and Hour Law, New York Wage Hour and Wage Payment Law, New York WARN Act, and retaliation provisions of New York
Workers’ Compensation Law, and all amendments to the foregoing, and any other federal, state or local statute, ordinance, regulation or constitutional provision regarding employment, compensation, employee benefits, termination of employment or
discrimination in employment. 
 Except as permitted by Section 11(d) of the Employment Agreement and explained below, I represent and affirm
(i) that I have not filed any Claim against the Company or Releasees and (ii) that to the best of my knowledge and belief, there are no outstanding Claims. 

For the purpose of implementing a full and complete release and discharge of Claims, I expressly acknowledge that this Release is intended to include in its
effect, without limitation, 

  
 A-1 

 
all the Claims described in the preceding paragraphs, whether known or unknown, apparent or concealed, and that this Release contemplates the extinction of all such Claims, including Claims for
attorney’s fees. I expressly waive any right to assert after the execution of this Release that any such Claim has, through ignorance or oversight, been omitted from the scope of the Release. 

For purposes of this Release, the term “the Company and Releasees” includes the Company and its past, present and future direct and indirect parents,
subsidiaries, affiliates, divisions, predecessors, successors, and assigns, and their past, present and future officers, directors, shareholders, representatives, agents, attorneys and employees, in their official and individual capacities, and all
other related individuals and entities, jointly and individually, and this Release shall inure to the benefit of and shall be binding and enforceable by all such entities and individuals. 

Notwithstanding anything in this Release to the contrary, I do not waive (i) my existing right to receive vested accrued benefits under plans or programs
of the Company under which I have accrued benefits (other than under any Company separation or severance plan or programs), (ii) any claims that, by law, may not be waived, (iii) any right to indemnification under the governing documents of the
Company or any indemnification agreement between me and the Company, or under any directors and officers insurance policy, with respect to my performance of duties as an officer or director of the Company, and (iv) any claim or right I may have
for unemployment insurance benefits, workers’ compensation benefits, state disability and/or paid family leave insurance benefits pursuant to the terms of applicable state law. 

I understand that nothing in this Release or the Employment Agreement restricts or prohibits me from initiating communications directly with, responding to
any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a
government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency
Inspector General (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However, I acknowledge that to the maximum extent
permitted by law, I am waiving my right to receive any individual monetary relief from the Company or any others covered by this Release resulting from such claims or conduct, regardless of whether I or another party has filed them, and in the event
I obtain such monetary relief the Company will be entitled to an offset for the payments made pursuant to this Release and the Employment Agreement. I understand that this Release and the Employment Agreement do not limit my right to receive an
award from any Regulator that provides awards for providing information relating to a potential violation of law. I further understand that I do not need the prior authorization of the Company to engage in conduct protected by this Paragraph, and
that I do not need to notify the Company that I have engaged in such conduct. 

  
 A-2 

 I have taken notice that federal law provides criminal and civil immunity to federal and state claims
for trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related
to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law. 

I acknowledge that for purposes of my entitlement to the payments and benefits set forth in Section 6 of the Employment Agreement, this Release will not
become effective unless and until I have signed and returned this Release to the Company, and have not revoked it pursuant to the following paragraph. 
 I
further acknowledge that I have had at least 21 days from my receipt of this Release, to review and consider this Release, to consult with an attorney prior to executing this Release, and have been provided 7 days to revoke my execution of this
Release by delivering a written notice of revocation to the Company. 
 I ACKNOWLEDGE THAT I HAVE READ 

THIS RELEASE, AND I UNDERSTAND 
 AND VOLUNTARILY ACCEPT ITS TERMS.

  

					
	  
	 		 	  

	Daniel Siegel	 		 	Date

  
 A-3Exhibit

Exhibit 10.2

TELLURIAN INC.
2017-2021 Long Term Incentive Compensation Program
(As adopted by Board of Directors on September 20, 2017 upon the recommendation of the Compensation Committee on September 20, 2017)

Purpose
Tellurian Inc. (the “Company”) hereby establishes and adopts this 2017-2021 Long Term Incentive Compensation Program (the “Program”) to provide long term incentive award opportunities to incentivize and retain employees and selected independent contractors, as recommended by senior management to the Committee (as defined below), of the Company and its Affiliates, contingent upon meeting certain performance goals.  Upon approval by the stockholders of the Company of the Amended and Restated Tellurian Inc. 2016 Omnibus Incentive Compensation Plan, this Program shall immediately become effective.
Overview
The Program is structured as a sub-plan under the Amended and Restated Tellurian Inc. 2016 Omnibus Incentive Compensation Plan, as amended from time to time (the “Plan”).  The Program sets forth the terms of the Company’s long-term equity incentive program for the 2017 through 2021 Performance Periods.  
Awards under the Program for any Performance Period (as defined below) depend upon total shareholder return during the applicable Performance Period and cumulatively over the life of the Program.
Unless otherwise defined in this Program, capitalized terms used herein shall have the meanings assigned to them in the Plan; provided, however, that with respect to Awards issued under the Program, capitalized terms shall have the meanings as may be set forth and otherwise defined in the Restricted Stock Award Agreement.
Performance Period
The term of the Program (the “Term”) will commence as of January 1, 2017 (the “Program Start Date”) and will consist of five consecutive annual performance periods.  
Each annual performance period during the Term (each, a “Performance Period”) will commence on January 1 (as applicable, the “Period Start Date”) and continue through December 31 of the calendar year in which the Period Start Date occurs (as applicable, the “Period End Date”).  
Administration of the Program
The Program shall be administered by the Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”) in accordance with the terms of the Plan and pursuant to the Committee’s authority under the Plan.  The Committee shall not delegate any matters 

involving compensation of the “Executive Officer Group,” which, for purposes of any Performance Period during the Term, will include the Company’s Chief Executive Officer (the “CEO”), the Chief Financial Officer of the Company (“CFO”), and any “officer” of the Company or any Affiliate within the meaning of Section 16 of the Exchange Act (the “Executive Officers”) and other employees of the Company and its Affiliates who the Committee determines, in its sole discretion, could be a “Covered Employee” under Code Section 162(m) as of the end of the fiscal year in which the Awards under the Program are issued for such Performance Period.
The Program is (and Awards granted hereunder are) subject to all of the provisions of the Plan, together with all of the rules and determinations from time to time issued by the Committee and by the Board pursuant to the Plan; provided, however, that in the event of a conflict between any provision of the Plan and the Program, the provisions of the Program shall control but only to the extent such conflict is permitted under the Plan.  
Eligibility
Except as otherwise delegated by the Committee in accordance with the Plan and applicable law, the Committee shall determine the employees and, taking into account the recommendations of senior management to the Company, selected independent contractors eligible to participate in the Program for any Performance Period (the “Participants”).  
Prior to the end of each Performance Period, except as otherwise delegated by the Committee in accordance with the Plan and applicable law, the Committee, in its sole discretion but taking into account the recommendations of senior management, shall select and identify the Participants that will be eligible to participate in the Program.  Notwithstanding the foregoing, to the extent that the Committee intends that Awards to the Executive Officer Group Participants for any Performance Period qualify as “performance-based compensation” within the meaning of the Plan and performance-based compensation as described in Section 162(m)(4)(C) of the Code (“Performance-Based Awards”), the determination and identification of the Executive Officer Group for the Performance Period shall be made by the Committee on a timely basis in accordance with the regulations under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”).   
For purposes of any Performance Period during the Term, the “Employee Group” will include the Participants who are not in the Executive Officer Group and who are selected and identified by the Committee (or its delegate in accordance with the Plan and applicable law) as eligible to participate in the Program.
Annual Share Pools
The aggregate long-term equity incentive pool (the “Aggregate Share Pool”) allocable for each Performance Period will be a number of restricted shares of the Company’s Common Stock equal to (x) 0.085 multiplied by (y) the TSV Growth and divided by (z) the Average Closing Stock Price.  The components of the Aggregate Share Pool shall be calculated according to the following definitions:

		
	▪
	“Average Closing Stock Price” means, as to any Performance Period, the simple average of the closing prices of the Company’s Common Stock as reported on the primary stock exchange on which the Company’s Common Stock is traded (as of the date of adoption of this Program, the Nasdaq Stock Market) (the “Primary Exchange”) for the final ten (10) days of the Performance Period.  The calculation of the Average Closing Stock Price shall not include any price for any day that is a weekend, holiday or any other day in which the Company’s Common Stock was not traded during such day on the Primary Exchange.  For the avoidance of doubt in the application of this section, the program start price will be $10.07, which is the 10-day average share price from December 21, 2016 through December 30, 2016. 

		
	§
	“Market Capitalization” means, as to any Performance Period, (i) the Average Closing Stock Price multiplied by (ii) the number of outstanding shares of the Company’s Common Stock as of the last day of the Performance Period. 

		
	§
	“Program Start Date TSV” means $2,014,000,000.  

		
	§
	“Total Shareholder Value” means, as to any Performance Period, (i) the Market Capitalization for such Performance Period; plus (ii) the aggregate amount paid by the Company for all repurchases of the Company’s Common Stock made by the Company since the effective date of the Program (not including the repurchase of any shares issued under the Plan, including this Program, for the net settlement of taxes owed by employees); minus (iii) the aggregate value of all stock issuances (not including any shares issued under the Plan, including this Program) since the effective date of the Program; plus (iv) the aggregate amount of all dividends paid to holders of the Company’s Common Stock since the effective date of the Program.  

		
	§
	“TSV Growth” means, as to any Performance Period, a positive amount equal to: (i) the Total Shareholder Value for such Performance Period; minus (ii) the greater of (x) the highest Total Shareholder Value achieved in any prior Performance Period and (y) the Program Start Date TSV.  If the TSV Growth is not a positive amount in excess of 0, then the TSV Growth will be deemed to be 0.

For any Performance Period, the amount of the Aggregate Share Pool, and all calculations and determinations in respect thereof, shall be prepared as soon as practicable after the end of the Performance Period (consistent with generally accepted accounting principles and/or as identified in the Company’s financial statements, notes to the financial statements, management’s discussion and analysis, or other Securities and Exchange Commission filings) and subject to the approval of the Committee.

Pool Allocations and Sharing Percentages

For purposes of this Program, any allocation of the Aggregate Share Pool to a Participant shall be referred to as his or her “Pool Allocation”, and a Participant’s Pool Allocation expressed as a percentage of the Aggregate Share Pool shall be referred to as his or her “Sharing Percentage.”  

Prior to, during or as soon as practicable after the end of a Performance Period, the Committee (or its delegate) shall determine the Pool Allocation and/or Sharing Percentage, if any, to be allocated to each Participant in respect of such Performance Period.  At any time, the Committee (or its delegate) may also determine the Sharing Percentage for any Participant for any or all future Performance Periods during the Term of the Program.

Notwithstanding the foregoing, the Committee may not delegate the responsibility for making allocations in respect of Participants in the Executive Officer Group, and to the extent Awards to such Participants in the Executive Officer Group for any such Performance Period are intended by the Committee to qualify as Performance-Based Awards, such determination shall be made by the Committee in writing on a timely basis in accordance with applicable Section 162(m) regulation.  

At any time following the determination of any allocation of the Aggregate Share Pool to a Participant for any Performance Period or Performance Periods, the Committee (or its delegate) may in its sole discretion communicate to such Participant the Pool Allocation and/or Sharing Percentages allocated to such Participant in writing promptly following the determination thereof (such written notice, an “Allocation Notice”).  

Any Sharing Percentage or Pool Allocation allocated to a Participant in the Executive Officer Group for any Performance Period who forfeits his or her right to receive an Award under the Program for such Performance Period may not be reallocated to any other Participant in the Executive Officer Group or otherwise result in an increase to any Pool Allocation or Sharing Percentages for any other Participant in the Executive Officer Group for such Performance Period, in each case, to the extent Awards to such other Participants in the Executive Officer Group under the Program for the Performance Period are intended to be Performance-Based Awards; provided, however, that nothing herein shall limit the ability of the Committee to reallocate any such forfeited Sharing Percentage or Pool Allocation (or to issue Restricted Shares in respect of any such reallocated Pool Allocation or Sharing Percentage) to any Participant within the first 90 days of the Performance Period, or at any time prior to payment with respect to a Participant who is not in the Executive Officer Group.
The Pool Allocations for Participants in the Employee Group and the Executive Officer Group, in the aggregate for any Performance Period, may not exceed the Aggregate Share Pool, and the Sharing Percentages for Participants in the Employee Group and the Executive Officer Group, in the aggregate for any Performance Period, may not exceed one hundred percent (100%).  

Except as provided below with respect to a Performance Period in which a Change of Control occurs, the Committee may determine, in its sole discretion, for any Performance Period, to reduce the Aggregate Share Pool, or to make total Pool Allocations to all Participants in an aggregate amount that is less than the Aggregate Share Pool and/or to establish total Sharing Percentages for all Participants in an aggregate percentage that is less than one hundred percent (100%), based on such factors as it determines to be appropriate, including, but not limited to, established Performance Goals, Company-wide or business-unit performance against budgeted financial goals, measures of internal controls and compliance initiatives, and assessments of individual performance. 

Determination of Individual Awards

Following the determination of the Aggregate Share Pool for a Performance Period, the Company shall issue awards of restricted shares of the Company’s Common Stock (“Restricted Shares”) under the Program pursuant to a written Restricted Stock Grant agreement.  
The number of Restricted Shares issued under an Award to any Participant in respect of any Performance Period shall be in an amount equal to the Participant’s Pool Allocation (and in the case of a Pool Allocation expressed in a Sharing Percentage, equal to the product of (i) the Participant’s Sharing Percentage, as the case may be, and (ii) the Aggregate Share Pool),   

Notwithstanding the foregoing, (A) the total number of shares of Common Stock that may be granted subject to Awards under the Program during the Term, in the aggregate, shall not exceed the number of shares of Common Stock reserved for issuance under Section 5 of the Plan, inclusive of all previously approved and unallocated shares; and (B) no more than the maximum number of shares of Common Stock that may be granted to any individual in any calendar year under Section 5 of the Plan may be granted to any Participant in any calendar year, including Awards granted under the Program or otherwise.  For purposes of the annual limits with respect to grants of Awards covering or relating to shares of Common Stock under Section 5 of the Plan, Awards issued under the Program shall only be deemed granted on the date of issuance of the Restricted Shares pursuant to a Restricted Stock Award Agreement.

Terms and Conditions of Awards
All Restricted Shares issued pursuant to the Program will be awarded no later than March 15 of the year following the last day of the applicable Performance Period, subject to the Participant’s continued employment in good standing through the date of grant.  A Participant whose employment terminates for any reason (or no reason) prior to the date of issuance of Awards for the applicable Performance Period will not receive an Award of Restricted Shares under the Program for the applicable Performance Period.  
Restricted Shares issued under the Program will be granted pursuant to a Restricted Stock Award Agreement having terms and conditions as set forth below, unless otherwise determined by the Committee and set forth in the applicable Restricted Stock Award Agreement:
		
	§
	Vesting.  The Restricted Shares shall vest and the forfeiture restrictions shall lapse as follows, in each case, subject to the Participant’s continued employment in good standing through the applicable vesting date: (i) 25% of the Restricted Shares will be vested as of the date of grant; and (ii) 25% of the Restricted Shares will vest on each of the first, second and third calendar years following the year in which the applicable Performance Period ends (e.g., for awards granted in respect of the initial Performance Period ending December 31, 2017, 25% would be vested on the date of grant in early 2018, and an additional 25% would vest on the anniversaries of the date of grant in each of 2019, 2020 and 2021).  Except as otherwise set forth below, upon the termination of a Participant’s employment with the Company and its Affiliates, all unvested Restricted Shares not then vested as of the date of termination shall not vest (except as otherwise provided herein) and shall be forfeited back to the Plan.

		
	§
	Termination of Employment due to Death or Disability. If the Participant’s employment with the Company or an Affiliate is terminated due to the death of the Participant or by the Company or an Affiliate due to the Disability of the Participant, then the Restricted Shares shall become vested and the forfeiture restrictions shall lapse as of the date of such termination as to all unvested Restricted Shares, provided that in the case of a termination due to Disability, such vesting is subject to the Participant’s continued compliance with all confidentiality obligations and restrictive covenants to which the Participant is subject.

		
	§
	Termination of Employment without Cause. If the Participant’s employment with the Company or an Affiliate is terminated by the Company or an Affiliate without “Cause,” then the Restricted Shares shall become vested and the forfeiture restrictions shall lapse as of the date of such termination as to all unvested Restricted Shares, subject to (x) the Participant’s timely execution and delivery to the Company (without revocation) of a general release of all claims of any kind that Participant has or may have against the Company and its Affiliates and their respective affiliates, officers, directors, employees, shareholders, agents and representatives, in a form satisfactory to the Company, within sixty (60) days following the date of termination, and (y) Participant’s continued compliance with all confidentiality obligations and restrictive covenants to which the Participant is subject.

The terms “Cause” and “Disability” as applied to any Award under the Program shall have the meaning set forth in the Plan, unless otherwise determined by the Committee and set forth in the applicable Restricted Stock Award Agreement.  

Change of Control
In the event that a Change of Control (as defined in the Plan) occurs during a Performance Period, then the TSV Growth for such Performance Period shall be determined as of such Change of Control, assuming for purposes of such determination that (i) the Period End Date for such Performance Period was the date of consummation of the Change of Control and (ii) the Average Closing Stock Price as of the last day of the Performance Period was equal to the aggregate consideration paid in such Change of Control divided by the number of shares of the Company’s Common Stock outstanding as of immediately prior to the consummation of the Change of Control.  The consideration paid in such Change of Control shall be deemed to be: (A) in the case of a sale, exchange or purchase of the Company’s equity securities, the total consideration paid for such securities (including the amount of any dividends paid to holders of the Company’s Common  Stock in connection with such Change of Control) and (B) in the case of a sale or disposition by the Company of all or substantially all of the Company’s assets, the total consideration paid for such assets, net of any required repayment of indebtedness by the Company in connection with such sale, plus the net value of any current assets and liabilities not sold by the Company.  
Notwithstanding anything in the Program to the contrary, prior to the consummation of a Change of Control, the Committee, taking into account the recommendations of senior management, shall fully allocate the Aggregate Share Pool for the Performance Period in which the Change of Control 

occurs among eligible Participants, such that the aggregate Sharing Percentages for all Participants for such Performance Period shall equal one hundred percent (100%).  Following the determination of the Aggregate Share Pool for such Performance Period, subject to and effective as of the Change of Control, the Company shall issue awards of Restricted Shares under the Program for such Performance Period that are fully vested and not subject to forfeiture restrictions as of the date of grant.  

Amendment and Termination
The Committee may at any time alter, amend, suspend, modify, restate, supplement or terminate the Program, including during a Performance Period; provided, however, that no such amendment, suspension or termination shall adversely affect any Awards previously granted under the Program to a Participant or any allocation of a Sharing Percentage communicated to a Participant pursuant to an Allocation Notice, and no amendment shall be made without the approval of the Company’s stockholders if the effect of such amendment would be to cause outstanding or pending Awards that are intended to be Performance-Based Awards to cease to qualify for the performance-based compensation exception to Section 162(m) of the Code.  The Company and its Affiliates shall be under no obligation to continue the Program after the 2021 Performance Period or to offer any other annual bonus program in any future period.  Notwithstanding anything herein to the contrary, the Committee may suspend, amend or terminate the Program and any Sharing Percentage and/or Allocation Notice following a Change of Control with respect to any or all future Performance Periods.  
Taxes 
The Company shall have the right to take any action as may be necessary or appropriate to satisfy any federal, state, local or any other tax withholding obligations or national insurance/social security obligations as it determines are necessary in relation to Awards under this Program and/or arising from the issuance, vesting or disposal of Awards acquired under the Program and/or the Plan.  Unless otherwise agreed to in writing by the Participant and the Company, or pursuant to the establishment by the Committee of an alternate procedure, (a) for a Participant who is an “officer” under Section 16 of the Exchange Act at the time of vesting, required withholding will be implemented through a net settlement of shares or (b) for a Participant who is not an “officer” under Section 16 of the Exchange Act at the time of vesting, required withholding will be required to be implemented through the Participant executing a “sell to cover” transaction through a broker designated or approved by the Company.   
Participants shall be solely responsible for and liable for any tax consequences (including but not limited to any interest or penalties) as a result of participation in the Program. None of the Board, the Company or the Committee makes any commitment or guarantee that any federal, state or local tax treatment will apply or be available to any person participating or eligible to participate hereunder and assumes no liability whatsoever for the tax consequences to the participants.
All Awards under the Program are intended to be exempt from or to comply with the requirements of Section 409A of the Code and shall be interpreted accordingly.  The Company makes no commitment or guarantee to Participants that any federal or state tax treatment will apply or be 

available to any person eligible for benefits under an Award and in no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed as a result of Section 409A or any damages for failing to comply with Section 409A.
The Company makes no commitment or guarantee to Participants that any particular United Kingdom tax treatment will apply or be available to any person eligible for benefits under an Award and in no event whatsoever shall the Company be liable for any tax, interest or penalty that may be imposed under any applicable United Kingdom employment tax legislation.  The Participant agrees to enter into any tax election that the Company requires that the Participant enter into with the Company or any Subsidiary (including the Employer) within any time period requested by the Company.  If the Company so requires as a condition of the Award, the Participant shall (i) enter into a joint election with the Employer under section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 in respect of the Restricted Stock within 14 days after the date of grant and (ii) appoint the Company as the Participant’s attorney to make any joint election and related arrangements.  Upon the making of such election, the Company and/or the Participant’s Employer shall have the right to take any action as may be necessary to comply with related reporting obligations and withholding obligations in respect of income tax and National Insurance Contributions which may arise from the making of such election. 

Miscellaneous
The obligations of the Company under the Program shall be binding upon any successor corporation or organization (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business and/or assets of the entity. 
No right or benefit under the Program shall be subject to alienation, sale, assignment, pledge, encumbrance, garnishment, execution or levy of any kind or charge, and any attempt to alienate, sell, assign, pledge, encumber and, to the extent permitted by applicable law, garnish, execute upon or levy upon the same, shall be void and shall not be recognized or given effect by the Company.
The Program and all determinations made and actions taken thereunder shall be governed by the laws of the State of Delaware.  
No person shall have any claim or right to participate in the Program or to receive any allocation or be issued any Award in the Program, in each case, except as otherwise determined by the Committee.  An allocation of a Sharing Percentage shall not confer on any Participant a right to continued employment with the Company.  The Company expressly reserves the right to terminate the employment or services of any Participant at any time. Any Award granted to any Participant shall remain subject to the terms thereof, including without limitation and as applicable, the Plan and any award agreement to which such Award may be subject.
The Program is not funded and any obligations under the Program arising from, or relating to, any Award shall constitute a general unsecured claim.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]